Our West Virginia Program to Increase Colorectal Cancer Screening (WV PICCS) partner clinics participated in national Dress in Blue Day on Friday, March 3. Dress in Blue Day began as a way to present a united front in the battle against the disease during Colorectal Cancer Awareness Month. Partner clinic staff donned their favorite shade a blue in order to raise awareness of colorectal cancer screening with their patients.
Colorectal cancer is the second leading cause of cancer-related deaths in West Virginia. While colorectal cancer is a significant problem, it does not have to be. If men and women aged 50 years and older tested regularly for colorectal cancer, we could avoid at least 60% of deaths from this disease. Colorectal cancer does not always have symptoms so it is important to test for it even if you feel healthy.
WV PICCS is a CDC-funded program directed through the WVU Cancer Institute Cancer Prevention and Control. The purpose is to increase colorectal cancer screening rates in persons aged 50-75 in partner primary care clinics across West Virginia. WV PICCS works with each partner clinic to assess their current screening practices. With this information, program staff collaborate with the clinics’ administrators, providers, and staff to implement evidence-based interventions to increase and sustain colorectal cancer screening rates. WV PICCS works with each partner clinic for a 2-year period with the goal to increase colorectal cancer screening rates to the national goal of 80% or at least 10% above their baseline. The program currently partners with 24 primary care clinics in 18 counties.
Thanks to all of our partner clinics for showing their support!
The WVU Cancer Institute is the first institution in the United States to offer intraoperative radiation therapy (IORT) to treat glioblastoma.
Several events at this year’s West Virginia Writers’ Workshop, July 20-23 at WVU, are focused on the role of writing and storytelling in health. Presenters include narrative medicine faculty from several campuses across the U.S., along with the leaders of an expressive writing program for patients at the WVU Cancer Institute. Health sciences faculty, staff and students are invited to participate in some or all of the Workshop.
WVU cancer researcher participates in study that shows promising treatments for certain patients with advanced colorectal cancer
A group of cancer researchers, including Richard Goldberg, M.D., director of the WVU Cancer Institute, released a study today in the Journal of the American Medical Association comparing the results of combinations of chemotherapy delivered with targeted therapy drugs in the treatment of people with advanced colorectal cancer who had not received prior drug treatment for their advanced disease.